Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Journal of Cellular Biochemistry. Supplement
|
February 14, 2002
Signal transduction driving technology driving signal transduction: factors in the design of targeted therapies
E A Golemis, M F Ochs, E N Pugacheva
Molekuliarnaia Biologiia
|
March 25, 2000
[Identification of genes activated by mutant forms of p53]
E N Pugacheva, A V Ivanov, I E Snegur, et al.
Genetika
|
May 1, 1995
[p53 with a mutation in codon 273 increases the probability of amplifying the dhfr gene in Rat-1 and LIM1215 cells]
G V Il'inskaia, E N Pugacheva, O I Sokova, et al.
Doklady Akademii Nauk
|
January 1, 1996
[The human adenosine deaminase gene contains a p53-responsive element]
R V Kondratov, E N Pugacheva, N V Kuznetsov, et al.
Molekuliarnaia Biologiia
|
May 1, 1996
[Functional heterogeneity of p53-responsive elements]
R V Kondratov, N V Kuznetsov, E N Pugacheva, et al.
Oncology Research
|
January 1, 1995
Influence of exogenous ras and p53 on P-glycoprotein function in immortalized rodent fibroblasts
B P Kopnin, T P Stromskaya, R V Kondratov, et al.
Oncogene
|
November 17, 2005
HEF1 is a necessary and specific downstream effector of FAK that promotes the migration of glioblastoma cells
M Natarajan, J E Stewart, E A Golemis, et al.
Oncogenesis
|
June 9, 2015
Kruppel-like factor 4 signals through microRNA-206 to promote tumor initiation and cell survival
C-C Lin, S B Sharma, M K Farrugia, et al.
Oncogene
|
September 23, 2014
NEDD9/Arf6-dependent endocytic trafficking of matrix metalloproteinase 14: a novel mechanism for blocking mesenchymal cell invasion and metastasis of breast cancer
Y V Loskutov, P Y Kozyulina, V K Kozyreva, et al.
Free Radical Biology & Medicine
|
June 16, 2025
Xanthine oxidoreductase expression is diminished in breast cancer as a response to uric acid mediated chelation of redox active iron
M G Chapa, R D King, Z W Dean, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Journal of Cellular Biochemistry. Supplement
|
February 14, 2002
Signal transduction driving technology driving signal transduction: factors in the design of targeted therapies
E A Golemis, M F Ochs, E N Pugacheva
Molekuliarnaia Biologiia
|
March 25, 2000
[Identification of genes activated by mutant forms of p53]
E N Pugacheva, A V Ivanov, I E Snegur, et al.
Genetika
|
May 1, 1995
[p53 with a mutation in codon 273 increases the probability of amplifying the dhfr gene in Rat-1 and LIM1215 cells]
G V Il'inskaia, E N Pugacheva, O I Sokova, et al.
Doklady Akademii Nauk
|
January 1, 1996
[The human adenosine deaminase gene contains a p53-responsive element]
R V Kondratov, E N Pugacheva, N V Kuznetsov, et al.
Molekuliarnaia Biologiia
|
May 1, 1996
[Functional heterogeneity of p53-responsive elements]
R V Kondratov, N V Kuznetsov, E N Pugacheva, et al.
Oncology Research
|
January 1, 1995
Influence of exogenous ras and p53 on P-glycoprotein function in immortalized rodent fibroblasts
B P Kopnin, T P Stromskaya, R V Kondratov, et al.
Oncogene
|
November 17, 2005
HEF1 is a necessary and specific downstream effector of FAK that promotes the migration of glioblastoma cells
M Natarajan, J E Stewart, E A Golemis, et al.
Oncogenesis
|
June 9, 2015
Kruppel-like factor 4 signals through microRNA-206 to promote tumor initiation and cell survival
C-C Lin, S B Sharma, M K Farrugia, et al.
Oncogene
|
September 23, 2014
NEDD9/Arf6-dependent endocytic trafficking of matrix metalloproteinase 14: a novel mechanism for blocking mesenchymal cell invasion and metastasis of breast cancer
Y V Loskutov, P Y Kozyulina, V K Kozyreva, et al.
Free Radical Biology & Medicine
|
June 16, 2025
Xanthine oxidoreductase expression is diminished in breast cancer as a response to uric acid mediated chelation of redox active iron
M G Chapa, R D King, Z W Dean, et al.
Page
of 1